Author:
Schwab D. M.,Katus H. A.,Raake P. W.
Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Baumgartner H, Falk V, Bax JJ et al (2018) 2017 ESC/EACTS guidelines for the management of valvular heart disease. Rev Esp Cardiol 71:67–73
2. Fleckenstein AE, Volz TJ, Riddle EL et al (2007) New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 47:681–698
3. Kaye S, Mcketin R (2005) Cardiotoxicity associated with methamphetamine use and signs of cardiovascular pathology among methamphetamine users. National Drug and Alcohol Research Centre, Sydney
4. Lopez JE, Yeo K, Caputo G et al (2009) Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance. J Cardiovasc Magn Reson 11:46
5. Paratz ED, Cunningham NJ, Macisaac AI (2016) The cardiac complications of methamphetamines. Heart Lung Circ 25:325–332
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献